Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. | J Pers Med | 2023 | 36983664 | PubTator, text mining | PubMed |
| Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. | Int J Mol Sci | 2023 | 36982681 | PubTator, text mining | PubMed |
| DNA Repair and Therapeutic Strategies in Cancer Stem Cells. | Cancers (Basel) | 2023 | 36980782 | PubTator, text mining | PubMed |
| Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study. | Cancers (Basel) | 2023 | 36980643 | PubTator, text mining | PubMed |
| Construct ceRNA Network and Risk Model of Breast Cancer Using Machine Learning Methods under the Mechanism of Cuproptosis. | Diagnostics (Basel) | 2023 | 36980514 | PubTator, text mining | PubMed |
| Licochalcone B Induces ROS-Dependent Apoptosis in Oxaliplatin-Resistant Colorectal Cancer Cells via p38/JNK MAPK Signaling. | Antioxidants (Basel) | 2023 | 36978904 | PubTator, text mining | PubMed |
Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis. | Curr Oncol | 2023 | 36975441 | PubTator, text mining | PubMed |
| Liver organoids: established tools for disease modeling and drug development. | Hepatol Commun | 2023 | 36972388 | PubTator, text mining | PubMed |
| Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy. | Front Cardiovasc Med | 2023 | 36970345 | PubTator, text mining | PubMed |
| Assessment of adaptive immune responses of dairy cows with Burkholderia contaminans-induced mastitis. | Front Microbiol | 2023 | 36960295 | PubTator, text mining | PubMed |
| Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 36950684 | PubTator, text mining | PubMed |
| Systematic analysis of the aberrances and functional implications of cuproptosis in cancer. | iScience | 2023 | 36950125 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma. | Front Genet | 2023 | 36936439 | PubTator, text mining | PubMed |
| Industrial Regenerator Model for SMTO Technology. | ACS Omega | 2023 | 36936298 | PubTator, text mining | PubMed |
| The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression. | Front Oncol | 2023 | 36925927 | PubTator, text mining | PubMed |
| Micronutrients and risks of three main urologic cancers: A mendelian randomization study. | Front Nutr | 2023 | 36923697 | PubTator, text mining | PubMed |
| Age and Serum Creatinine Can Differentiate Wilson Disease Patients with Pseudonormal Ceruloplasmin. | Int J Clin Pract | 2023 | 36915635 | PubTator, text mining | PubMed |
| A cuproptosis-related signature for predicting the prognosis of gastric cancer. | J Gastrointest Oncol | 2023 | 36915443 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| Association of polycythemia vera with non‑cirrhotic portal hypertension in five patients: A case series. | Exp Ther Med | 2023 | 36911372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=36